Hopazid TB 1120

Hopazid TB 1120 is an antibiotic injection that contains the combination of Ceftazidime 1000mg and Tobramycin 120mg. Ceftazidime is a third generation cephalosporin antibiotic that functions by interfering with the bacterial cell wall formation. Tobramycin belongs to the aminoglycoside class of antibiotics and works by interfering with bacterial protein synthesis. These antibacterial agents work together and provides proper coverage against bacterial infections.

Hopazid TB 1120 is mostly used in hospital and critical care settings where it is required to inject the antibacterial therapy. Ceftazidime is used against minor bacterial infections whereas tobramycin injections are used in some serious bacterial infections that includes respiratory and other infections that depends on the suspected organism and clinical circumstances.

Composition

Each Hopazid-TB 1120 injection contains:

• Ceftazidime – 1000mg
• Tobramycin – 120mg

The combination should be administered only according to the prescribing healthcare professional’s instructions. The appropriate dose, route, frequency and duration depend on factors such as the type and severity of infection, patient’s age, weight, kidney function, and clinical response.

Key Features of HOPAZID-TB 1120

• Contains Ceftazidime 1000mg + Tobramycin 120mg
• Injectable antibiotic formulation for prescription use
• Designed for use in clinical and critical-care settings
• Combines a cephalosporin antibiotic with an aminoglycoside antibiotic
• Suitable for use only under qualified medical supervision

Safety Information

Hopazid-TB 1120 should not be self-administered. Antibiotics should be used only when bacterial infection is suspected or confirmed and according to professional medical advice. Tobramycin can cause nephrotoxicity (kidney toxicity) and ototoxicity (hearing or balance-related toxicity), so patients receiving it may require monitoring of kidney function and, where clinically appropriate, drug levels.

Patients should inform their doctor about any history of kidney problems, hearing or balance disorders, allergies to antibiotics, pregnancy, breastfeeding, or other medicines they are taking. Dosage adjustments may be necessary in patients with impaired renal function.

Frequently Asked Questions

1. What is Hopazid-TB 1120 used for?

Hopazid-TB 1120 is a prescription injectable antibiotic containing ceftazidime 1000mg and tobramycin 120mg. It may be used by healthcare professionals for the management of susceptible bacterial infections when combination antibacterial therapy is considered appropriate.

2. What is the composition of Hopazid-TB 1120?

Hopazid-TB 1120 contains Ceftazidime 1000mg + Tobramycin 120mg per injection.

3. Is Hopazid-TB 1120 an antibiotic?

Yes. It contains two antibacterial medicines: ceftazidime, a cephalosporin antibiotic, and tobramycin, an aminoglycoside antibiotic.

4. Can Hopazid-TB 1120 be taken without a prescription?

No. Hopazid-TB 1120 is an injectable prescription medicine and should be administered only under the direction and supervision of a qualified healthcare professional.

5. Does Hopazid-TB 1120 require kidney monitoring?

Kidney monitoring may be required because tobramycin can cause kidney toxicity. Healthcare professionals may monitor renal function and, in appropriate cases, serum tobramycin concentrations during treatment.

6. Can Hopazid-TB 1120 treat viral infections?

No. Antibiotics such as ceftazidime and tobramycin are intended for bacterial infections and do not treat viral infections such as the common cold or influenza.

7. What precautions are important with Hopazid-TB 1120?

Patients should inform their healthcare provider about kidney disease, hearing problems, previous antibiotic allergies, pregnancy or breastfeeding, and all medicines currently being used. The medicine should be administered according to the prescribed dose and schedule.